ReviewZeitschrift fur Rheumatologie2021
[Data analysis in rheumatology practices : Possibilities, limitations, and results].
Review in Zeitschrift fur Rheumatologie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data analyses in rheumatology practices can be used as a feedback system in quality management. Implementation of a representative patient survey enables evaluation of one's own work and can be used for external presentation of the practice. Patient education and the structured use of specialist rheumatology assistants were evaluated by means of a survey. Systematic screening for depressive symptoms was carried out and enables a better understanding of patients and their "unmet needs". An analysis of the diseases and the patients in terms of physical function, disease activity, medication, and concomitant diseases is possible using structured patient documentation in a specialized documentation system. Within the RHADAR network (RheumaDatenRhePort G.b.R.), the proportion of rheumatoid arthritis patients treated with Janus kinase inhibitors was compared between different centers. Patients suitable for clinical trials can be filtered out of a structured documentation system.
Indexed as
Identifiers
34618210What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.